Download FREE Report Sample
Download Free sampleThe global Pulmonary Function Testing Systems market was valued at 35.27 Million USD in 2021 and will grow with a CAGR of 4.37% from 2021 to 2027, based on Research newly published report.
The prime objective of Pulmonary Function Testing Systems Market is to provide the insights on the post COVID-19 impact wwhich will help market players in this field evaluate their business approaches. Also, Pulmonary Function Testing Systems Market covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Pulmonary Function Testing (PFT) is a complete evaluation of the respiratory system including patient history, physical examinations, chest x-ray examinations, arterial blood gas analysis, and tests of pulmonary function. The primary purpose of pulmonary function testing is to identify the severity of pulmonary impairment. Pulmonary function testing has diagnostic and therapeutic roles and helps clinicians answer some general questions about patients with lung disease. Europe`s sales volume accounted for the highest market share (28.23%) in 2016, followed by the North America and China. At present, the manufactures of Pulmonary Function Testing Systems are concentrated in North America, Europe, China and Japan. Europe is the largest production area in the world, which occupied about 31.42% production share in 2016. The global leading players in this market are CareFusion(BD), Schiller, CHEST, COSMED, nSpire Health, NDD MGC Diagnostics, etc. The Pulmonary Function Testing Systems are mainly used by Hospitals, Physical Examination Center and Physician Groups. The dominant application of Pulmonary Function Testing Systems is Hospitals. In the last few years, the total number of high-tech Pulmonary Function Testing Systems developed by domestic manufacturers is limited. This shows that the efforts to develop high-tech product in China is not enough, but also shows that the allocation space of domestic Pulmonary Function Testing Systems still need to expand. There is still a big gap compared with the imported Pulmonary Function Testing Systems. Despite the presence of competition problems, as large demand of high-tech products at home and abroad, many companies began to enter the field of high-tech, emergence of technological advancements, investors are still optimistic about this area, the future will still have more new investment enter the field. But it is suggested that enterprises those have plans to enter this industry have careful analysis of this market and the advantages or disadvantages of themselves.
By Market Verdors:
By Types:
By Applications:
Key Indicators Analysed
Key Reasons to Purchase
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy